GroinPain Trial: the effect of a neurectomy compared with an injection with lidocain, corticosteroids and hyaluronic acid on postherniorrhaphy inguinodynia

ISRCTN ISRCTN93771787
DOI https://doi.org/10.1186/ISRCTN93771787
Protocol serial number N/A
Sponsor Maxima Medical Center (The Netherlands)
Funder MÁxima Medical Center (The Netherlands)
Submission date
28/12/2006
Registration date
28/12/2006
Last edited
26/03/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R M H Roumen
Scientific

Maxima Medical Center
Department of Surgery
P.O. Box 7777
Veldhoven
5500 MB
Netherlands

Study information

Primary study designInterventional
Study designRandomised, controlled, parallel group trial
Secondary study designRandomised controlled trial
Scientific titleGroinPain Trial: the effect of a neurectomy compared with an injection with lidocain, corticosteroids and hyaluronic acid on postherniorrhaphy inguinodynia
Study objectivesThe pain reductive effect of a neurectomy of the ilio-inguinal, ilio-hypogastric or/and genital branch of the genito-femoral nerve(s) is significantly more compared to an injection with lidocain, corticosteroids and hyaluronic acid for neuropathic groin pain syndrome.
Ethics approval(s)Approval received from the Medical Ethics Board Maxima Medical Centre on the 1st May 2006 (ref: 0543).
Health condition(s) or problem(s) studiedInguinal Pain
InterventionNeurectomy of ilio-inguinal, ilio-hypogastric or/and genital branch of the genito-femoral nerve(s) compared with an injection with lidocaine, corticosteroids and hyaluronic acid on postherniorrhaphy inguinodynia.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Lidocaine, corticosteroids and hyaluronic acid
Primary outcome measure(s)

Change on pain score (Surgical Pain Scales and McGill Pain Questionnaire - Dutch Language Version).

Key secondary outcome measure(s)

1. Complications
2. Alterations in inguinal neurophysiological status (Leeds Assessment of Neuropathic Symptoms and Signs [LANNS] pain scale)
3. Quality of life (Short Form health survey [SF-36] version II)
4. Change in employment status

Completion date01/02/2008

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration54
Total final enrolment54
Key inclusion criteria1. Nerve entrapment or damage of ilio-inguinal, ilio-hypogastric or/ and genital branch of the genito;-femoral nerve(s) confirmed with peripheral nerve blockade with Lidocaine
2. Corrected inguinal hernia
3. Inguinal pain more than three months
4. Age of 18 yrs or older
5. Adequate follow-up possible
Key exclusion criteria1. Presence of inguinal hernia recurrence
2. Local inguinal inflammatory signs
3. Patient classified as American Society of Anaesthesiologist Class three or more
Date of first enrolment01/02/2006
Date of final enrolment01/02/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Maxima Medical Center
Veldhoven
5500 MB
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 01/05/2018 26/03/2021 Yes No

Editorial Notes

26/03/2021: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.